Evidence map›Paper›PMID 40447983›Full record

ReviewInflammopharmacology2025

Natural therapy proposed for the management of diabetic peripheral neuropathy (DPN).

Rana M Merghany, Rofida A Saleh, Ahmed A Hamed, Ahmed M El-Dessouki, Riham A El-Shiekh, Eman S Zaki, Amal M Mahfoz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rana M MerghanyDepartment of Pharmacognosy, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 33 El-Buhouth Street, Giza, 12622, Egypt.
Rofida A SalehDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Ahmed A HamedDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt.
Ahmed M El-DessoukiPharmacology and Toxicology Department, Faculty of Pharmacy6 of October City, Ahram Canadian University, Giza, 12566, Egypt.
Riham A El-ShiekhDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt. riham.adel@pharma.cu.edu.eg.ORCID http://orcid.org/0000-0002-3179-3352
Eman S ZakiPharmacology and Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
Amal M MahfozEgyptian Drug Authority, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 50% of patients with diabetes mellitus (DM) are known to have significant side effects, including retinopathy, cardiomyopathy, peripheral neuropathy, and nephropathy. Most of these complications are caused by inadequate glycemic control or incorrect pathology management. In any event, diabetic peripheral neuropathy (DPN) appears to be the most common and painful consequence that many DM patients experience. As a result, this review aimed to gather the wide range of treatments used to manage DPN, beginning with the most traditional therapy and progressing to alternative approaches. Medicinal plants and their bioactive compounds have been widely used as natural medicines for various diseases, with little known adverse effects. This review emphasizes the role of medicinal plants and their naturally occurring bioactive components in combating this condition.

Indexed as

Complementary and alternative medicineDiabetesDiabetic peripheral neuropathyNeuropathic pain

Identifiers

PMID40447983

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.